Company profile: Cortex E&P
1.1 - Company Overview
Company description
- Provider of an integrated suite of technologies for assessing and treating atrial fibrillation (AFib) with precision, simplicity, and speed.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cortex E&P
Vascular Concepts
HQ: India
Website
- Description: Provider of cutting-edge medical devices for the treatment of arterial diseases that are affordable for the common man.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vascular Concepts company profile →
Celera
HQ: United States
Website
- Description: Provider of molecular diagnostic products and services that leverage knowledge of human variability to personalize disease management, enabling hospitals and clinical laboratories to detect, characterize, monitor, and select treatment for disease, including genotyping for infections diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Celera company profile →
Aldagen
HQ: United States
Website
- Description: Provider of proprietary regenerative cell therapies addressing inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure. The biopharmaceutical company has four product candidates in clinical trials, including lead candidate ALD-101 in a pivotal Phase 3 trial to evaluate its efficacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aldagen company profile →
CorFlow Therapeutics
HQ: Switzerland
Website
- Description: Provider of proprietary medtech technologies to diagnose and treat microvascular obstructions (MVO) in heart attack patients. Offers the CoFI System for post-PCI coronary microcirculation assessment and controlled infusion of diagnostic/therapeutic agents, the CoFI Console acting as an infusion pump and displaying physiological parameters, an infusion-occlusion CoFI Catheter, and a single-use CoFI Cassette.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CorFlow Therapeutics company profile →
Procyrion
HQ: United States
Website
- Description: Provider of catheter-based circulatory support technologies, including Aortix, a catheter-deployed pump that augments blood flow from the aortic arch to the lower aorta, reduces aortic root pressure, and increases renal perfusion to support patients with acute decompensated heart failure, renal support needs, and chronic heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Procyrion company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cortex E&P
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cortex E&P
2.2 - Growth funds investing in similar companies to Cortex E&P
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cortex E&P
4.2 - Public trading comparable groups for Cortex E&P
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →